Mar 25
|
Court adviser sides with Illumina in EU row that triggered Grail fine
|
Mar 24
|
14 Best Medical Device Stocks To Buy Now
|
Mar 22
|
Exact Sciences (EXAS) Up 4.2% Since Last Earnings Report: Can It Continue?
|
Mar 21
|
Why Illumina Stock Zoomed Higher on Thursday
|
Mar 21
|
UPDATE 2-EU merger powers may be curbed after court adviser backs Illumina fight
|
Mar 21
|
EU merger powers may be curbed after court adviser backs Illumina fight
|
Mar 18
|
A Biobank for the Americas and a Genomics Lab Power Precision Health for All
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
Mar 13
|
10 Biggest Stocks Targeted By Activist Investors Right Now
|
Mar 12
|
Carl Icahn Drops Plans for New Proxy Fight at Illumina
|
Mar 12
|
Exclusive-Icahn drops Illumina board challenge threat, sources say
|
Mar 8
|
Finding the Needle in the Genomic Haystack With DRAGEN
|
Mar 7
|
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
|
Mar 7
|
Video: Give Someone a Fish, You Feed Them - Unlock the Fish Genome, You Feed the World
|
Jan 19
|
Here’s Why Polen Focus Growth Sold Illumina (ILMN)
|
Jan 19
|
Illumina, Inc. (NASDAQ:ILMN) is largely controlled by institutional shareholders who own 90% of the company
|
Jan 18
|
Here’s How the New AI Algorithm Helps Illumina (ILMN)
|
Jan 16
|
Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results
|
Jan 15
|
Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world
|
Jan 12
|
What 5000 Ancient Human Genomes Can Reveal About European Health and Heritage
|